Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 5181-5185

  Marshall, William L ^a   Yim, Ching ^a   Gustafson, Erik ^b   Graf, Thomas ^a   Sage, David R ^b   Hanify, Katherine ^a   Williams, Louisa ^a   Fingeroth, Joyce ^b   Finberg, Robert W ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSFECTION; HELA CELL; HERPES VIRUS; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTO ONCOGENE; SEQUENCE HOMOLOGY; VIRUS INFECTION;

EID: 0033057256     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.5181-5185.1999     Document Type: Article

References (44)

1. Altschul, S., W. Gish, W. Miller, E. Myers, and D. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Baer, R., A. Bankier, M. Biggin, P. Deininger, P. Farreli, T. Gibson, G. Hatfull, G. Hudson, S. Satchwell, C. Seguin, P. Tuffnell, and B. Barrell. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Bailey, T., and C. Elkan. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers, p. 28-36. In Proceedings of the Second International Conference on Intelligent Systems for Molecular Biology. AAAI Press, Menlo Park, Calif.
4. Boise, L., M. Gonzalez-Garcia, C. Postema, L. Ding, T. Lindsten, L. Turka, X. Mao, G. Nunez, and C. Thompson. 1993. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
5. Brun, A., C. Rivas, M. Esteban, J. Escribano, and C. Alonso. 1996. African swine fever virus gene A179L, a viral homologue of bcl-2, protects cells from programmed cell death. Virology 225:227-230.
6. Carbone, A., U. Tirelli, A. Golghini, R. Volpe, and M. Boicchi. 1993. Human immunodeficiency virus-associated systematic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J. Clin. Oncol. 11:1674-1681.
7. Castedo, M., T. Hirsch, S. A. Susin, N. Zamzami, P. Marchetti, A. Macho, and G. Kroemer. 1996. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol. 157: 512-521.
8. Cheng, E., D. Kirsch, R. Clem, R. Ravi, M. Kastan, A. Bedi, K. Ueno, and J. Hardwick. 1997. Conversion of bcl-2 to a bax-like death effector by caspases. Science 278:1966-1968.
9. Cheng, E., J. Nicholas, D. Bellows, G. Hayward, H. Guo, M. Reitz, and J. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690-694.
10. Cohen, G. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16.
11. Farrell, P. J. 1989. Epstein-Barr genome, p. 103-132. In G. Klein (ed.), Advances in viral oncology; tumorigenic DNA viruses, vol. 8. Raven Press, Ltd., New York, N.Y.
12. Ghayur, T., M. Hugunin, R. Talanian, S. Ratnofsky, C. Quinlan, Y. Emoto, P. Pandey, R. Datta, Y. Huang, S. Kharabanda, H. Allen, R. Kamen, W. Wong, and D. Kufe. 1996. Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J. Exp. Med. 184:2399-2404.
13. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-8483.
14. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
15. Hengartner, M., and H. Horvitz. 1994. Activation of C. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in bcl-2. Nature 369:318-320.
16. Hennequin, C., N. Giocanti, J. Balosso, and V. Favaudon. 1994. Interaction of ionizing radiation with the topoisomerase I poison Camptothecin in growing V-79 and HeLa cells. Cancer Res. 54:1720-1728.
17. Hershberger, P., D. LaCount, and P. Friesen. 1994. The apoptotic suppressor p35 is required early during baculovirus replication and is targeted to the cytosol of infected cells. J. Virol. 68:3467-3477.
18. Kamada, S., A. Shimono, Y. Shinto, T. Tsujimura, T. Takahashi, T. Noda, Y. Kitamura, H. Kondoh, and Y. Tsujimoto. 1995. bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55:354-359.
19. Knudson, C., K. Tung, W. Tourtellolte, G. Brown, and S. J. Korsmeyer. 1995. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96-99.
20. Komano, J., M. Sugiura, and K. Takada. 1998. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J. Virol. 72:9150-9156.
21. Kroemer, G. 1997. The proto-oncogene bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
22. Lakshmi, R., M. Debbas, Sabbatini, D. Hockenberry, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
23. Lee, J., and A. Berenstein. 1995. Apoptosis, cancer, and the p53 tumor suppressor gene. Cancer Metastasis Rev. 14:149-161.
24. Lee, M., and J. Yates. 1992. BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogenc bcl2, is not essential for transformation of B cells or for virus replication in vitro. J. Virol. 66:1899-1906.
25. Mandal, M., S. Maggirwar, N. Sharma, S. Kaufmann, S. Sun, and R. Kumar. 1996. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J. Biol. Chem. 271:30354-30354.
26. Marchini, A., B. Tomkinson, J. Cohen, and E. Kieff. 1991. BHRF1, the Epstein-Barr virus gene with homology to bcl-2, is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 65:5991-6000.
27. Murray, P., L. Swinnen, C. Constandinou, J. Pyle, T. Carr, J. Hardwick, and R. Ambinder. 1996. Bcl-2 but not its EBV-encoded homologue, BHRF1, is commonly expressed in postransplantation lymphoproliferative disorders. Blood 87:706-711.
28. Nakayama, K., I. Negishi, K. Kuida, H. Sawa, and D. Loh. 1994. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91:3700-3704.
29. Nava, V., E. Cheng, M. Veliuona, S. Zou, R. Clem, M. Mayer, and J. Hardwick. 1997. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:4118-4122.
30. Nicoletti, I., G. Migliorati, M. C. Pagliacc, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
31. Park, S.-Y., and R. Raines. 1997. Green fluorescent protein as a signal for protein-protein interactions. Protein Sci. 6:2344-2349.
32. Pearson, W., and D. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA 85:2444-2448.
33. Sarid, R., T. Sato, R. Bohenzky, J. Russo, and V. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat. Med. 3:293-298.
34. Shibasaki, F., E. Kondo, T. Akagi, and F. McKeon. 1997. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 386:728-731.
35. Shibata, M., L. Wiess, A. Hernandez, B. Nathwani, L. Bernstein, and A. Levine. 1993. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients with the human immunodeficiency virus. Blood 81:2102-2109.
36. Smith, R., and T. F. Smith. 1992. Pattern-induced multi-sequence alignment algorithm employing secondary structure-dependent gap penalties for use in comparative protein modeling. Protein Eng. 5:35-41.
37. Spector, M., S. Desnoyers, D. Hoeppner, and M. Hengartner. 1994. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 385:653-656.
38. Telford, E., M. Watson, H. Aird, J. Perry, and A. Davison. 1995. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249:520-528.
39. Thome, M., P. Schneider, K. Hofman, H. Fickenscher, E. Meini, F. Neipel, C. Mattman, K. Burns, J.-L. Bodmer, M. Schroter, C. Scaffidi, P. Krammer, M. Peter, and J. Tschopp. 1997. Viral FLICE-inhibitory proteins (FLIPS) prevent apoptosis induced by death receptors. Nature 386:517-521.
40. Thompson, C. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
41. Tsujimoto, Y., L. Finger, J. Yunis, P. Nowell, and C. Croce. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 266:1097-1099.
42. Veis, D., C. Sorenson, J. Shutter, and S. Korsmeyer. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
43. Yin, X.-M., Z. Oltvai, and S. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321-323.
44. Zou, H., W. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.